内镜下逆行阑尾炎治疗术与阑尾切除术或抗生素治疗在非复杂性急性阑尾炎现代治疗中的比较:系统评价与Meta分析
该系统评价检索MEDLINE、Cochrane对照试验中心注册库和EMBASE(末次检索2023年4月),纳入6项研究。内镜下逆行阑尾炎治疗术与阑尾切除术或抗生素治疗在入院期间技术成功率和1年随访疗效上无显著差异,但内镜下逆行阑尾炎治疗术可缩短操作时间和住院时间,且1年阑尾炎复发风险增加。
要点
- 内镜下逆行阑尾炎治疗术与阑尾切除术在入院期间技术成功率无差异(RR 0.97,95%CI 0.92-1.02)。
- 阑尾切除术在1年随访复发方面优于内镜下逆行阑尾炎治疗术(RR 11.28,95%CI 2.61-48.73)。
- 内镜下逆行阑尾炎治疗术较抗生素治疗缩短住院时间(MD -1.91,95%CI -3.18至-0.64),但复发风险无差异。
核心结论
- 该Meta分析未发现内镜下逆行阑尾炎治疗术与阑尾切除术或抗生素治疗在入院期间技术成功率和1年随访治疗疗效方面存在显著差异。
- 然而,高偏倚风险(不精确性)限制了这些结果。
- 内镜下逆行阑尾炎治疗术在缩短操作时间和住院时间方面的优势必须与1年阑尾炎复发风险增加相权衡。
研究设计与样本
- 系统评价与Meta分析,检索MEDLINE、Cochrane对照试验中心注册库和EMBASE,末次检索为2023年4月。
- 共纳入6项研究;其中4项比较内镜下逆行阑尾炎治疗术(n=236)与阑尾切除术(n=339),2项比较内镜下逆行阑尾炎治疗术(n=269)与抗生素治疗(n=280)。
- 二分类变量计算风险比(RR)及95%置信区间(CI),连续变量计算均数差(MD)及95%CI。
- 使用Cochrane偏倚风险2.0工具(随机对照试验)和非随机干预研究偏倚风险工具(非随机对照试验)评估偏倚风险。
主要发现
- 内镜下逆行阑尾炎治疗术与阑尾切除术比较:入院期间技术成功率无差异(RR 0.97,95%CI 0.92-1.02);阑尾切除术在1年随访复发方面更优(RR 11.28,95%CI 2.61-48.73)。
- 内镜下逆行阑尾炎治疗术与阑尾切除术比较:内镜下逆行阑尾炎治疗术操作时间更短(MD -14.38,95%CI -20.17至-8.59),住院时间更短(MD -1.19,95%CI -2.37至-0.01),干预后腹痛更少(RR 0.21,95%CI 0.14-0.32)。
- 内镜下逆行阑尾炎治疗术与抗生素治疗比较:入院期间技术成功率无差异(RR 1.11,95%CI 0.91-1.35),阑尾炎复发无差异(RR 1.07,95%CI 0.08-14.87),但内镜下逆行阑尾炎治疗术缩短住院时间(MD -1.91,95%CI -3.18至-0.64)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 高偏倚风险(不精确性)限制了这些结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Endoscopic retrograde appendicitis therapy has been proposed as an alternative strategy for treating appendicitis, but debate exists on its role compared with conventional treatment. METHODS: This systematic review was performed on MEDLINE, Cochrane Central Register of Controlled Trials, and EMBASE. The last search was in April of 2023. The risk ratio with a 95% confidence interval was calculated for dichotomous variables, and the mean difference with a 95% confidence interval for continuous variables. The risk of bias was assessed using the Cochrane Risk of Bias 2.0 tool (randomized controlled trials) and the Risk of Bias in Non-Randomized Studies of Intervention tool (non-randomized controlled trials). RESULTS: Six studies met the eligibility criteria. Four studies compared endoscopic retrograde appendicitis therapy (n = 236 patients) and appendectomy (n = 339) and found no differences in technical success during index admission (risk ratio 0.97, 95% confidence interval [0.92,1.02]). Appendectomy showed superior outcomes for recurrence at 1-year follow-up (risk ratio 11.28, 95% confidence interval [2.61,48.73]). Endoscopic retrograde appendicitis therapy required shorter procedural time (mean difference -14.38, 95% confidence interval [-20.17, -8.59]) and length of hospital stay (mean difference -1.19, 95% confidence interval [-2.37, -0.01]), with lower post-intervention abdominal pain (risk ratio 0.21, 95% confidence interval [0.14,0.32]). Two studies compared endoscopic retrograde appendicitis therapy (n = 269) and antibiotic treatment (n = 280). Technical success during admission (risk ratio 1.11, 95% confidence interval [0.91,1.35]) and appendicitis recurrence (risk ratio 1.07, 95% confidence interval [0.08,14.87]) did not differ, but endoscopic retrograde appendicitis therapy decreased the length of hospitalization (mean difference -1.91, 95% confidence interval [-3.18, -0.64]). CONCLUSION: This meta-analysis did not identify significant differences between endoscopic retrograde appendicitis therapy and appendectomy or antibiotics regarding technical success during index admission and treatment efficacy at 1-year follow-up. However, a high risk of imprecision limits these results. The advantages of endoscopic retrograde appendicitis therapy in terms of reduced procedural times and shorter lengths of stay must be balanced against the increased risk of having an appendicitis recurrence at one year.
引用
- Pata F, Nardo B, Ielpo B, et al. Endoscopic retrograde appendicitis therapy versus appendectomy or antibiotics in the modern approach to uncomplicated acute appendicitis: A systematic review and meta-analysis. Surgery. 2023. PMID: 37806859. doi:10.1016/j.surg.2023.08.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。